Femasys Inc
NASDAQ:FEMY
Intrinsic Value
Femasys, Inc. operates as a medical device company that focuses on women's healthcare. [ Read More ]
The intrinsic value of one FEMY stock under the Base Case scenario is 1.46 USD. Compared to the current market price of 1.47 USD, Femasys Inc is Overvalued by 1%.
Valuation Backtest
Femasys Inc
Run backtest to discover the historical profit from buying and selling FEMY stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Our AI Assistant is coming soon! Stay tuned and thank you for your interest!
Provide an overview
of Femasys Inc's business.
What risks and challenges
does Femasys Inc face in the near future?
Summarize the latest earnings report
of Femasys Inc.
Provide P/E
for Femasys Inc and its competitors.
Balance Sheet Decomposition
Femasys Inc
Current Assets | 10.2m |
Cash & Short-Term Investments | 8.7m |
Receivables | 103.6k |
Other Current Assets | 1.4m |
Non-Current Assets | 4.6m |
PP&E | 3.7m |
Intangibles | 390 |
Other Non-Current Assets | 937k |
Current Liabilities | 2.2m |
Accounts Payable | 851.9k |
Accrued Liabilities | 569.4k |
Other Current Liabilities | 765.6k |
Non-Current Liabilities | 2.2m |
Long-Term Debt | 2.2m |
Other Non-Current Liabilities | 54k |
Earnings Waterfall
Femasys Inc
Revenue
|
1.1m
USD
|
Cost of Revenue
|
-376.2k
USD
|
Gross Profit
|
708.2k
USD
|
Operating Expenses
|
-13.8m
USD
|
Operating Income
|
-13.1m
USD
|
Other Expenses
|
334.4k
USD
|
Net Income
|
-12.7m
USD
|
Free Cash Flow Analysis
Femasys Inc
What is Free Cash Flow?
FEMY Profitability Score
Profitability Due Diligence
Femasys Inc's profitability score is 27/100. The higher the profitability score, the more profitable the company is.
Score
Femasys Inc's profitability score is 27/100. The higher the profitability score, the more profitable the company is.
FEMY Solvency Score
Solvency Due Diligence
Femasys Inc's solvency score is 53/100. The higher the solvency score, the more solvent the company is.
Score
Femasys Inc's solvency score is 53/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
FEMY Price Targets Summary
Femasys Inc
According to Wall Street analysts, the average 1-year price target for FEMY is 8.67 USD with a low forecast of 5.05 USD and a high forecast of 12.6 USD.
Ownership
FEMY Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Shareholder Return
FEMY Price
Femasys Inc
Average Annual Return | -72.1% |
Standard Deviation of Annual Returns | 7.56% |
Max Drawdown | -97% |
Market Capitalization | 31.8m USD |
Shares Outstanding | 21 649 600 |
Percentage of Shares Shorted | 2.5% |
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Femasys, Inc. operates as a medical device company that focuses on women's healthcare. The company is headquartered in Suwanee, Georgia. The company went IPO on 2021-06-18. The firm is focused on providing women worldwide with non-surgical product technologies, accessible in the office, improving patient care and overall health economics. The firm has two lead product candidates: FemBloc and FemaSeed. FemBloc is a permanent birth control solution in development. FemaSeed is an artificial insemination infertility treatment. The firm also offers FemVue Saline-Air device for diagnosis of infertility and FemCerv Endocervical Sampler for diagnosis of cervical cancer. FemCerv is a sterile, single-use disposable endocervical curettage product that can be used to sample cervical cells and tissue, including in support of further testing following an abnormal Pap test to assess for any problems such as cancer, in a relatively pain-free office procedure.
Contact
IPO
Employees
Officers
The intrinsic value of one FEMY stock under the Base Case scenario is 1.46 USD.
Compared to the current market price of 1.47 USD, Femasys Inc is Overvalued by 1%.